Merck Investors Can't Use Vioxx News Report In Fraud MDL
A New Jersey federal judge on Wednesday allowed a class of Merck & Co. Inc. investors to tweak its securities fraud suit against the drugmaker for a sixth time but barred...To view the full article, register now.
Already a subscriber? Click here to view full article